Taken together, it seems likely that while CLL cells are relatively quiescent in the peripheral blood, BCR-signaling in PCs in LNs promotes an upregulation of glycolysis and oxidative phosphorylation to support cellular proliferation and drive the disease. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.